Young Jonathan
Insider CIK 1779805 · AKRO Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,074 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 84,051 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 44,982 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 28,584 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 74,053 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 29,073 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 141,205 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 70,279 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 2,328 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 5,032 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer deriv | 2025-12-09 | 2025-12-09 | 3,421 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 152,616 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 47,573 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | D To issuer | 2025-12-09 | 2025-12-09 | 20,000 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | G Gift | 2025-11-26 | 2025-11-26 | 9,259 | — | $0 | 200,189 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-24 | 2025-11-26 | 4,739 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-24 | 2025-11-26 | 3,527 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-11-24 | 2025-11-26 | 4,284 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-24 | 2025-11-26 | 3,527 | $28.35 | $100.0K | 204,709 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-24 | 2025-11-26 | 4,739 | $21.10 | $100.0K | 209,448 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-11-24 | 2025-11-26 | 4,284 | $21.09 | $90.3K | 201,182 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-10-01 | 2025-10-03 | 12,500 | — | $0 | 44,982 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-10-01 | 2025-10-03 | 4,201 | $47.98 | $201.6K | 196,898 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-10-01 | 2025-10-03 | 8,299 | $47.64 | $395.4K | 201,099 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-10-01 | 2025-10-03 | 12,500 | $21.10 | $263.8K | 209,398 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-11 | 2025-09-12 | 586 | $43.02 | $25.2K | 196,898 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-09-02 | 2025-09-04 | 12,500 | — | $0 | 57,482 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-02 | 2025-09-04 | 2,739 | $47.14 | $129.1K | 197,545 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-02 | 2025-09-04 | 61 | $47.58 | $2.9K | 197,484 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-09-02 | 2025-09-04 | 12,500 | $21.10 | $263.8K | 209,984 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-09-02 | 2025-09-04 | 9,700 | $45.78 | $444.1K | 200,284 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-08-12 | 2025-08-13 | 12,500 | — | $0 | 69,982 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-12 | 2025-08-13 | 1,349 | $48.32 | $65.2K | 197,484 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-08-12 | 2025-08-13 | 11,151 | $47.72 | $532.1K | 198,833 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-08-12 | 2025-08-13 | 12,500 | $21.10 | $263.8K | 209,984 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2025-06-30 | 2025-07-02 | 890 | $23.87 | $21.2K | 197,484 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-18 | 2025-06-20 | 1,453 | $54.84 | $79.7K | 196,594 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-06-10 | 2025-06-12 | 2,493 | $53.99 | $134.6K | 198,047 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-12 | 2025-03-14 | 607 | $44.88 | $27.2K | 200,540 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-04 | 2025-03-05 | 38,553 | $45.07 | $1.74M | 201,147 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-03-04 | 2025-03-05 | 11,447 | $44.17 | $505.6K | 239,700 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 5,100 | $53.57 | $273.2K | 256,047 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-02-03 | 2025-02-05 | 4,900 | $54.06 | $264.9K | 251,147 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2025-01-24 | 2025-01-27 | 43,064 | $6.36 | $273.9K | 261,147 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2025-01-23 | 2025-01-27 | 43,064 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2025-01-02 | 2025-01-06 | 10,000 | $28.03 | $280.3K | 218,083 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2024-12-16 | 2024-12-18 | 73,700 | — | $0 | 73,700 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-12-16 | 2024-12-18 | 24,300 | — | $0 | 228,083 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 2,503 | $30.79 | $77.1K | 203,783 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-12-02 | 2024-12-04 | 10,000 | $32.13 | $321.3K | 206,286 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-11-01 | 2024-11-05 | 40,716 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-11-01 | 2024-11-05 | 40,716 | $21.09 | $858.7K | 267,002 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 34,943 | $31.25 | $1.09M | 232,059 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 15,481 | $32.27 | $499.6K | 216,578 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-11-01 | 2024-11-05 | 292 | $32.94 | $9.6K | 216,286 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-10-14 | 2024-10-16 | 40,000 | — | $0 | 40,716 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-14 | 2024-10-16 | 40,000 | $30.15 | $1.21M | 226,286 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-10-14 | 2024-10-16 | 40,000 | $21.09 | $843.6K | 266,286 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-10-01 | 2024-10-03 | 10,000 | $28.18 | $281.8K | 226,286 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-10 | 2024-09-13 | 568 | $26.18 | $14.9K | 236,286 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 3,710 | $26.42 | $98.0K | 238,144 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-09-03 | 2024-09-05 | 1,290 | $27.58 | $35.6K | 236,854 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-01 | 2024-08-02 | 3,031 | $26.44 | $80.1K | 243,823 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-08-01 | 2024-08-02 | 1,969 | $27.23 | $53.6K | 241,854 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-07-01 | 2024-07-02 | 5,000 | $23.40 | $117.0K | 246,854 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2024-06-28 | 2024-07-02 | 1,064 | $19.94 | $21.2K | 251,854 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-11 | 2024-06-13 | 2,516 | $22.64 | $57.0K | 250,790 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-06-03 | 2024-06-05 | 5,000 | $19.29 | $96.5K | 253,306 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-05-01 | 2024-05-02 | 5,000 | $20.15 | $100.8K | 258,306 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 400 | $25.03 | $10.0K | 263,306 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-04-01 | 2024-04-03 | 4,600 | $24.33 | $111.9K | 263,706 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2024-03-13 | 2024-03-15 | 651 | $28.33 | $18.4K | 268,306 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2024-03-01 | 2024-03-05 | 83,321 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2024-03-01 | 2024-03-05 | 83,321 | $0.62 | $51.7K | 268,957 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-12-27 | 2023-12-29 | 5,414 | — | $0 | 43,064 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-12-27 | 2023-12-29 | 5,414 | $6.36 | $34.4K | 190,545 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-27 | 2023-12-29 | 5,414 | $24.00 | $129.9K | 185,131 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-12-14 | 2023-12-18 | 543 | $20.76 | $11.3K | 185,131 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2023-12-08 | 2023-12-12 | 146,237 | — | $0 | 146,237 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2023-12-08 | 2023-12-12 | 32,497 | — | $0 | 185,674 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-11-17 | 2023-11-21 | 30,000 | $14.68 | $440.4K | 153,177 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-10-02 | 2023-10-04 | 490 | — | $0 | 86,731 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-10-02 | 2023-10-04 | 490 | $51.10 | $25.0K | 183,177 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-10-02 | 2023-10-04 | 490 | $21.10 | $10.3K | 183,667 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-09-13 | 2023-09-25 | 562 | $50.34 | $28.3K | 183,177 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-06-13 | 2023-06-15 | 538 | $55.16 | $29.7K | 183,739 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | F Tax w/h | 2023-03-10 | 2023-03-14 | 634 | $43.47 | $27.6K | 184,277 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2023-01-03 | 2023-01-05 | 8,777 | — | $0 | 83,321 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2023-01-03 | 2023-01-05 | 8,777 | $0.62 | $5.4K | 193,688 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2023-01-03 | 2023-01-05 | 8,777 | $54.64 | $479.6K | 184,911 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-27 | 2022-12-28 | 722 | — | $0 | 92,098 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-12-27 | 2022-12-28 | 11,778 | — | $0 | 48,478 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-27 | 2022-12-28 | 722 | $0.62 | $448 | 183,171 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-12-27 | 2022-12-28 | 12,500 | $49.57 | $619.6K | 182,449 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-12-27 | 2022-12-28 | 11,778 | $6.36 | $74.9K | 194,949 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-16 | 2022-12-20 | 29,073 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-12-09 | 2022-12-13 | 86,379 | — | $0 | 86,379 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2022-12-09 | 2022-12-13 | 19,195 | — | $0 | 182,449 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-10-25 | 2022-10-27 | 12,500 | — | $0 | 60,256 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-10-25 | 2022-10-27 | 12,500 | $6.36 | $79.5K | 175,754 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2022-10-25 | 2022-10-27 | 12,500 | $44.72 | $559.0K | 163,254 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-13 | 2022-09-13 | 29,074 | — | $0 | 58,148 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2022-09-09 | 2022-09-13 | 29,074 | — | $0 | 29,074 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-01-07 | 2022-01-11 | 1,448 | — | $0 | 92,820 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2022-01-07 | 2022-01-11 | 26,296 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2022-01-07 | 2022-01-11 | 27,744 | $0.62 | $17.2K | 163,254 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2021-12-08 | 2021-12-10 | 87,221 | — | $0 | 87,221 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-11-04 | 2021-11-05 | 6,220 | $24.33 | $151.3K | 135,510 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-11-03 | 2021-11-05 | 18,780 | $24.27 | $455.8K | 141,730 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-09-01 | 2021-09-03 | 12,500 | $24.04 | $300.5K | 160,510 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-07-15 | 2021-07-19 | 9,000 | — | $0 | 26,296 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-07-15 | 2021-07-19 | 9,000 | $0.62 | $5.6K | 173,010 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 3,055 | $26.24 | $80.2K | 164,010 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-05-03 | 2021-05-04 | 3,055 | $30.56 | $93.4K | 167,065 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-04-01 | 2021-04-05 | 3,055 | $28.75 | $87.8K | 170,120 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 200 | $31.17 | $6.2K | 173,175 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-03-01 | 2021-03-02 | 2,855 | $30.43 | $86.9K | 173,375 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-02-01 | 2021-02-02 | 200 | $29.92 | $6.0K | 176,230 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-02-01 | 2021-02-02 | 2,855 | $29.19 | $83.3K | 176,430 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-01-08 | 2021-01-11 | 10,000 | $28.12 | $281.2K | 179,285 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2021-01-07 | 2021-01-11 | 7,500 | — | $0 | 35,296 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2021-01-07 | 2021-01-11 | 7,500 | $0.62 | $4.7K | 189,285 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-01-04 | 2021-01-06 | 2,960 | $25.27 | $74.8K | 181,885 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | S Sale | 2021-01-04 | 2021-01-06 | 100 | $26.00 | $2.6K | 181,785 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2020-12-08 | 2020-12-09 | 77,580 | — | $0 | 77,580 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award | 2020-06-30 | 2020-12-09 | 1,245 | $17.07 | $21.3K | 184,845 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-03-13 | 2020-03-16 | 5,035 | — | $0 | 42,796 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-03-13 | 2020-03-16 | 6,082 | — | $0 | 94,268 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-03-13 | 2020-03-16 | 5,035 | $0.62 | $3.1K | 177,518 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-03-13 | 2020-03-16 | 6,082 | $0.62 | $3.8K | 183,600 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-10 | 21,286 | — | $0 | 100,350 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise deriv | 2020-01-10 | 2020-01-10 | 17,621 | — | $0 | 47,831 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-01-10 | 2020-01-10 | 17,621 | $0.62 | $10.9K | 211,197 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | M Exercise | 2020-01-10 | 2020-01-10 | 21,286 | $0.62 | $13.2K | 232,483 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | W Will | 2019-12-30 | 2019-12-31 | 667 | — | $0 | 193,576 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | A Award deriv | 2019-12-13 | 2019-12-13 | 85,000 | — | $0 | 85,000 | SEC↗ |